Powering microbiome discovery
Fast, reliable microbiome analysis using cutting-edge genomics and informatics.
Diversigen and CoreBiome have united
Fast. Accurate. Predictive.
Accelerate Your Discoveries
Diversigen offers fast, reliable microbiome analysis using cutting-edge genomics and informatics. We help customers with study design and collection through to data generation and full custom analysis.
Precise. Controlled. Scaleable.
Expert Microbiome Analysis
Quality is Everything.
We control every step of microbiome analysis, from the moment your samples are collected to the final data analysis.
Iterate faster. Get insight sooner.
Our platform is designed around generating fast, accurate, massive data sets to help you iterate the scientific process and get to insights faster.
Diversigen combines meticulous sample processing and DNA sequencing with machine learning to help you discover the next breakthrough.
Neutral. Stable. Reproducible.
Samples not collected yet?
Ask about OMNIgene® collection kits from our sister company, DNA Genotek. Take a ‘snapshot’ of the in vivo state right at the moment of collection. Ensure your microbiome profiles represent the phenotype of interest, not artifacts of overgrowth or degradation.
In the news
OraSure Technologies, Inc. announces that its Diversigen and CoreBiome subsidiaries have combined their microbiome service offerings under the Diversigen name. The rebrand highlights the combined companies’ unparalleled scientific bench strength, state-of-the-art laboratory, ability to translate data to insights and collective focus on quality and service. Investor Contact: Roberto Cuca Chief Financial
In this article we’re sharing results from the validation study scientists at Diversigen and DNA Genotek undertook to ensure Diversigen’s viral metagenomics capabilities could be leveraged to help during the COVID-19 pandemic. When I was a boy and I would see scary things in the news, my mother would say
Acquisition extends OraSure’s leadership position in the microbiome services industry BETHLEHEM, Pa., Nov. 06, 2019 (GLOBE NEWSWIRE) — OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic tests and specimen collection and stabilization devices, today announced that it has entered into a definitive agreement to acquire the outstanding equity of Diversigen
Discover where our services can take you.
Diversigen provides services and generates data for research purposes only. Not all services are available in all regions.